A recent review conducted by The Pirbright Institute has shed light on the inefficacy of global control strategies in preventing sustained mammal-to-mammal transmission of bird flu. Published in Nature, the study led by zoonotic influenza expert Dr. Thomas Peacock examined outbreaks in European fur farms, South American marine mammals, and United States dairy cattle, raising concerns about the potential for human transmission.
The researchers analyzed the changing ecology and molecular evolution of the H5N1 virus in wild and domestic birds, identifying new evolutionary pathways that could facilitate the transmission of avian influenza to mammals and eventually to humans. Historically, swine have been considered intermediary hosts that facilitate the adaptation of avian influenza viruses to mammalian hosts before jumping to humans. However, the altered ecology of H5N1 has created opportunities for novel transmission routes.
One of the key findings of the review was the existence of gaps in current control mechanisms, including a lack of engagement with modern vaccine and surveillance technologies, as well as incomplete data collection on H5N1 transmission between cows and humans on US dairy farms. The authors highlighted the need for improved testing criteria and surveillance practices to detect and prevent the silent spread of the virus.
The study also underscored the role of genomic reassortment in driving the global H5N1 outbreak, with the exchange of genetic material between different strains of the virus leading to the emergence of novel hybrids. The reassortment between H5N8 and low pathogenicity avian influenza viruses in Europe or central Asia gave rise to the panzootic H5N1 virus in the Americas, infecting marine mammals and dairy cattle in the US.
In light of these findings, the researchers emphasized the need for new control strategies, including vaccination, to curb the spread of H5N1 in mammalian populations. While current poultry vaccines can reduce disease burden, they do not prevent infection entirely. The availability of H5 vaccine stocks that are antigenically related to circulating strains provides a potential solution, especially if H5N1 begins spreading in humans.
The severity of a future H5N1 pandemic remains uncertain, with recent human infections exhibiting lower fatality rates compared to previous outbreaks in Asia. However, the susceptibility of younger individuals born after the 1968 H3N2 pandemic to severe disease raises concerns about the potential impact of a widespread H5N1 outbreak.
Overall, the review conducted by The Pirbright Institute highlights the urgent need for improved control strategies and surveillance measures to prevent the further spread of bird flu and mitigate the risk of a human pandemic. Further research and collaboration are essential to address the evolving challenges posed by the global H5N1 panzootic.
